Best Fit Profiles
- anti-inflammatory baseline protocols
Inflammation and joint-metabolic support
Curcumin
Curcumin can reduce pain and inflammation markers in some trials, but results depend on formulation quality and absorption.
Evidence Level B
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Modest reductions in inflammatory markers and joint discomfort
- Safety
- Low Risk
Bioavailability differs substantially by formulation and may interact with anticoagulants.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- 500-1500 mg standardized extract
- Timing
- With meals, often split into two doses
- Protocol Duration in Studies
- 8-24 weeks in inflammation-focused studies
Absorption-enhanced preparations can materially change effective exposure.